Home
NewsNewsSmart IUD to track uterus in real-time is being worked upon by Verso Biosense, which will help with data that has in the past been pretty hard to get, offering continuous intrauterine insights for better reproductive care.
Verso Biosense, which is based out of Oxfordshire, is working on an intrauterine device - IUD to track the uterus in real-time that can measure important physiological conditions like temperature and oxygen levels consistently for several days. The company says the technology could help scientists learn more about one of the least known organs in the human body by giving them data that has been difficult to get in the past.
The smart IUD to track the uterus in real-time looks like a regular IUD, but it has tiny sensors inside that collect data all the time and send it wirelessly for evaluation. The device is being looked into as a way to monitor uterine conditions in women who have had unsuccessful IVF cycles in order to find the circumstances that give embryos the best chance of a successful implantation.
Kate Rowley, the CEO of Verso Biosense, said, “Medicine has made extraordinary advances in many fields, but the uterus is still something of a black box. Our goal is to shine a light inside the uterine environment and gather the data needed to truly understand how it functions. Once we can see what’s happening in real time, we can start developing far more personalized and effective treatments.”
There are studies in science demonstrating that elements like temperature and oxygen levels can affect how embryos grow, but it has been very difficult to measure such factors directly inside the uterus. Verso Biosense wants to create large-scale datasets over time that show patterns across menstrual cycles. This kind of long-term data is not there as of now.
As per Rowley, “To really understand reproductive health, we need longitudinal data – potentially monitoring biomarkers over months or years. That’s a huge engineering challenge when the device itself is extremely small.”
In the years to come, intrauterine monitoring could be used for more than just fertility research. It could also be used to study endometriosis, PCOS, uterine cancers, perimenopause, and menopause. This would add a new layer of data to conditions that are still not well-defined because there is no direct physiological measurement.
As more families pursue fertility treatments, IVF CRYO urges greater transparency and safety in better Safe Embryos and Eggs Shipping across the U.S.
China sees a rise in advanced maternal age In Vitro Fertilization, driven by BaseCare Medical’s AI undisturbed culture system that improves embryo quality and clinical pregnancy rates, especially with PGT. Localized AI-assisted solutions position BaseCare as a leader in smart, precision reproduction technology for older IVF patients.
According to a landmark large-scale IVF trial, using natural ovulation for frozen embryo transfers achieves matching birth rates to standard hormone cycles, offering a safer alternative for women.
IVI RMA North America has launched the IVI RMA Patient Advisory Council in the US and Canada to strengthen patient-centered care. The councils bring patients, clinicians, and leadership together in structured monthly discussions, ensuring real patient experiences inform fertility care improvements, service innovation, and long-term clinical strategies.
Conceivable Life Sciences' AURA, world's first AI-powered automated IVF lab, has successfully delivered 18 healthy babies since April 2025. The revolutionary robotic system automates 200+ IVF steps with unprecedented precision, promising to make fertility treatment more accessible, affordable, and consistent while eliminating human error in embryo creation.
Infertility Treatment Drugs from Merck have enabled the births of 6 million babies globally, with 50% of conceived individuals tied to its therapies.
EMD Serono will offer steep IVF drug discounts via TrumpRx.gov in 2026 and seek expedited FDA review for Pergoveris, aligning with a White House order.
